(CC) Chemours - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1638511089
CC: Refrigerants, Pigments, Plastics, Coatings
Chemours Co (NYSE:CC) is a global leader in the production of performance chemicals, serving diverse industries across North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three distinct business segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions division delivers innovative refrigerants, thermal management solutions, and specialty solvents under the Freon and Opteon brands, catering to the growing demand for sustainable cooling solutions and thermal efficiency. The Titanium Technologies segment produces high-quality TiO2 pigments under the Ti-Pure brand, which are essential for coatings, plastics, and packaging applications, offering superior whiteness, durability, and opacity. The Advanced Performance Materials segment provides specialty products, including membranes, industrial resins, and coatings, under the Teflon, Viton, Krytox, and Nafion brands, serving critical markets such as consumer electronics, semiconductors, and energy.
Chemours distributes its products through a combination of direct and indirect channels, leveraging a global network of resellers, third-party sales agents, and distributors. The company, incorporated in 2014 and headquartered in Wilmington, Delaware, has established itself as a key player in the diversified chemicals industry. Its product portfolio addresses a wide range of applications, from industrial manufacturing to consumer goods, positioning it as a vital supplier to multiple sectors. For more information, visit their website at https://www.chemours.com.
3-Month Forecast: - Price Range: Based on the SMA 20 (11.57) and SMA 50 (13.35), the stock is expected to trade between $11.50 and $14.00 over the next three months. - Momentum: The bearish crossover of SMA 20 below SMA 50 indicates potential downside pressure. - Volatility: ATR of 0.86 suggests moderate price fluctuations. - Valuation: With a P/S ratio of 0.32 and a forward P/E of 7.36, the stock may attract value investors, potentially driving limited upside. - Outlook: The stock is likely to remain range-bound unless driven by positive earnings surprises or macroeconomic tailwinds.Additional Sources for CC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CC Stock Overview
Market Cap in USD | 1,823m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception | 2015-07-01 |
CC Stock Ratings
Growth Rating | -16.1 |
Fundamental | -23.7 |
Dividend Rating | 56.6 |
Rel. Strength | -54.6 |
Analysts | 3.44/5 |
Fair Price Momentum | 10.29 USD |
Fair Price DCF | - |
CC Dividends
Dividend Yield 12m | 6.74% |
Yield on Cost 5y | 9.71% |
Annual Growth 5y | 0.00% |
Payout Consistency | 80.9% |
CC Growth Ratios
Growth Correlation 3m | -85.7% |
Growth Correlation 12m | -82.5% |
Growth Correlation 5y | -7.3% |
CAGR 5y | 1.77% |
CAGR/Max DD 5y | 0.02 |
Sharpe Ratio 12m | -1.82 |
Alpha | -74.08 |
Beta | 2.007 |
Volatility | 91.06% |
Current Volume | 5541.7k |
Average Volume 20d | 2282.7k |
As of May 10, 2025, the stock is trading at USD 11.24 with a total of 5,541,740 shares traded.
Over the past week, the price has changed by -7.87%, over one month by +17.33%, over three months by -36.41% and over the past year by -56.94%.
Neither. Based on ValueRay Fundamental Analyses, Chemours is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -23.72 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CC as of May 2025 is 10.29. This means that CC is currently overvalued and has a potential downside of -8.45%.
Chemours has received a consensus analysts rating of 3.44. Therefor, it is recommend to hold CC.
- Strong Buy: 1
- Buy: 2
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CC Chemours will be worth about 11.2 in May 2026. The stock is currently trading at 11.24. This means that the stock has a potential downside of -0.62%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19.5 | 73.5% |
Analysts Target Price | 24.2 | 115.5% |
ValueRay Target Price | 11.2 | -0.6% |